Azurity Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.azurity.com
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
25
FDA:25
Drug Approvals
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
FDA Approves Nilotinib Tablets (Danziten) Without Mealtime Restrictions for CML
The FDA has approved nilotinib tablets (Danziten) for Philadelphia chromosome-positive chronic myeloid leukemia (CML) patients, offering a new treatment option.